The score is not available for this stock. This could be because (a) the market cap of the... Read More
Value score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
Price Momentum score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
QVM score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
CONCORD Key Metrics
CONCORD Share Price
Stock Analysis
Snapshot
Shareholding Pattern
Bulk, Block & Insider Trades
Corporate Actions
Company Profile
CONCORD Share Price
CONCORD
1 Week returns: -
1 Month returns: -
1 Year returns: -
3 Years CAGR: -
5 Years CAGR: -
Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
CONCORD Stock Analysis
Views
Red Flags
Positive
Low Debt to Equity, not much change from last year
Negative
Expensive and at a premium to industry median P/E
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Low ROE but improving trend
Low operating margin but improving trend
Stock in ASM list
The stock has been places in Additional Surveillance Measure (ASM) list (LTASM - I).
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.109698.
Snapshot
See detailed analysis
CONCORD Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
CONCORD Bulk, Block & Insider Trades
CONCORD Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
No capital change events found
Company Profile
Concord Drugs Limited is an India-based pharmaceutical company. The Companys principal activity is to manufacture licensed drugs based on the formulations approved. The Company is focused on developing drug delivery systems, including multiple unit pellet system (MUPS), sustained release, and modifi... Read More
Key personnel
Mr. Seelam Nagi ReddyD
Executive Chairman of the Board, Managing Director
Mr. Seelam Koni ReddyD
Chief Financial Officer, Whole time Director
Ms. Namratha Nagla
Compliance Officer, Company Secretary
Mr. S. Manoj Kumar ReddyD
Additional Whole-Time Director
Mrs. K. SumeelaD
Independent Director
Mr. Satyam Reddy GopidiD
Additional Non-Executive Independent Director
Mr. S. Nagavenkata HareeshD
Additional Non-Executive Independent Director
Mr. K. Ramachandra ReddyD
Non-Executive Independent Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Concord Drugs Ltd.?
The current share price of Concord Drugs Ltd. is ₹ 83.06 as of 09 Jan 2026.
What is the PE ratio of Concord Drugs Ltd.?
The Price-to-Earnings (PE) ratio of Concord Drugs Ltd. is 144.30 as of the latest financial data.
What is the ROE and ROCE of Concord Drugs Ltd.?
Concord Drugs Ltd. has a Return on Equity (ROE) of 1.69% and a Return on Capital Employed (ROCE) of 5.81% as per the latest financial reports.
What is the market cap of Concord Drugs Ltd.?
The market capitalization of Concord Drugs Ltd. stands at ₹ 83.06 Cr.
What is the dividend yield of Concord Drugs Ltd.?
The dividend yield of Concord Drugs Ltd. is 0.00% based on the current market price.
What is the RSI of Concord Drugs Ltd.?
The Relative Strength Index (RSI) of Concord Drugs Ltd. is 49.76.
What is the FII and DII holding in Concord Drugs Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.00% of Concord Drugs Ltd. shares.
What sector does Concord Drugs Ltd. belong to?
Concord Drugs Ltd. operates in the Healthcare sector.
What is the beta of Concord Drugs Ltd. stock?
The beta of Concord Drugs Ltd. stock is 0.57, indicating its volatility relative to the broader market.
